XML 55 R31.htm IDEA: XBRL DOCUMENT v3.10.0.1
SCHEDULE OF SHARE-BASED COMPENSATION, STOCK OPTIONS AND STOCK APPRECIATION RIGHTS AWARD ACTIVITY (Details) - Stock Appreciation Rights (SARs) [Member] - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value     $ 62.68    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $ 13,566   $ 13,566    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 59.32   $ 59.32   $ 57.75
Share-based Compensation Arrangement By Share-based Payment Award, Options and Stock Appreciation Rights, Outstanding [Roll Forward]          
Beginning of Year (in shares) 1,476,763   1,476,763    
Grants in Period (in shares) 9,415 12,076 509,046 455,807  
Exercises in Period (in shares)     186,662    
Forfeitures in Period (in shares)     168,824    
Weighted Average Exercise Price, Exercises in Period (in dollars per share)     $ 40.73    
Weighted Average Exercise Price, Forfeitures in Period (in dollars per share)     69.12    
Weighted Average Exercise Price, Exercisable (in dollars per share) $ 58.03   $ 58.03    
Weighted Average Remaining Contractual Term, Outstanding (in years)     6 years 3 months    
Weighted Average Remaining Contractual Term, Exercisable (in years)     4 years 11 months    
Aggregate Intrinsic Value, Outstanding $ 16,779   $ 16,779    
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 2,392,167   2,392,167   2,238,607